Barbara K. Finck

Insider Reports History

Entity
Individual
Location
C/O Protine Design Lab, 3858 Jackson St, San Francisco, California
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barbara K. Finck:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Comera Life Sciences Holdings, Inc. Director Common Stock 23K $1.63K $0.07 Jan 4, 2023 Direct
Forte Biosciences, Inc. Director Stock Option (right to buy) 175K Mar 21, 2024 Direct
Comera Life Sciences Holdings, Inc. Director Stock Option (Right to Buy) 37.1K May 19, 2022 Direct
Comera Life Sciences Holdings, Inc. Director Warrant (Right to Buy) 6.76K Jan 4, 2023 Direct

Insider Reports Filed by Barbara K. Finck

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FBRX Forte Biosciences, Inc. Mar 21, 2024 1 $0 4 Mar 25, 2024 Director
FBRX Forte Biosciences, Inc. Sep 19, 2023 1 $0 4 Sep 20, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Jan 4, 2023 2 $10K 4/A Feb 14, 2023 Director
CMRA Comera Life Sciences Holdings, Inc. Dec 31, 2022 1 $0 5 Feb 14, 2023 Director
FBRX Forte Biosciences, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
CMRA Comera Life Sciences Holdings, Inc. May 19, 2022 0 $0 3 May 20, 2022 Director
FBRX Forte Biosciences, Inc. Mar 16, 2022 1 $0 4/A May 16, 2022 Director
FBRX Forte Biosciences, Inc. Mar 16, 2022 0 $0 3 Mar 18, 2022 Director